Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Biotech Vaneck ETF (BBH)

Biotech Vaneck ETF (BBH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family Van Eck Associates
  • Assets Under Management 359,096,000
  • Market Capitalization, $K 359,096
  • Shares Outstanding, K 2,597
  • 60-Month Beta 1.32
  • Price/Earnings ttm 24.39
  • Annual Dividend & Yield 0.47 (0.35%)
  • Most Recent Dividend 0.472 on 12/23/19
  • Management Fee 0.35%
  • Sectors:

    ETFs - Biotech

Price Performance

See More
Period Period Low Period High Performance
1-Month
135.14 +0.46%
on 01/24/20
142.60 -4.80%
on 01/10/20
-7.09 (-4.97%)
since 12/24/19
3-Month
123.10 +10.28%
on 10/25/19
143.02 -5.08%
on 12/23/19
+11.31 (+9.09%)
since 10/24/19
52-Week
113.89 +19.20%
on 10/02/19
143.02 -5.08%
on 12/23/19
+10.44 (+8.33%)
since 01/24/19

Most Recent Stories

More News
Top ETF Areas for 2020

As ETF investing constantly climbs the popularity charts, we highlight a few good ETF areas that investors can bank on for 2020.

XHB : 48.10 (-1.31%)
XBI : 90.75 (-2.69%)
VWO : 44.29 (-0.76%)
IBB : 116.88 (-2.19%)
QCLN : 26.89 (-1.10%)
SCHE : 27.21 (-0.84%)
BBH : 135.76 (-1.79%)
PALL : 227.05 (-3.07%)
ITB : 48.41 (-1.20%)
PKB : 35.79 (-1.05%)
FBT : 145.47 (-2.02%)
ICLN : 12.43 (+0.08%)
TAN : 33.38 (-0.24%)
EEM : 44.60 (-0.80%)
PZD : 51.24 (-0.14%)
Deal or No Deal: Healthcare ETFs to Make a Sweep in 2020

While all eyes are on the fate of the phase one trade deal between the United States and China, Healthcare sector can forget tension and soar higher in 2020 even if there is no deal.

BBH : 135.76 (-1.79%)
VHT : 192.63 (-1.77%)
XBI : 90.75 (-2.69%)
XLV : 102.46 (-1.67%)
IYH : 216.63 (-1.72%)
Is Trade Scaring You? ETF Strategies for 2019 Holiday Season

It is less likely that Santa alone will drive Wall Street this season as trade tensions persist. Overall, these ETF investing trends should stay strong.

AMZN : 1,861.64 (-1.22%)
SHOP : 465.48 (-0.80%)
PYPL : 116.98 (-0.77%)
FTEC : 77.04 (-0.45%)
LVHI : 27.16 (-0.11%)
IBUY : 53.06 (-1.10%)
IBB : 116.88 (-2.19%)
IPAY : 52.68 (-0.55%)
VGT : 260.26 (-0.52%)
XBI : 90.75 (-2.69%)
BBH : 135.76 (-1.79%)
XLK : 97.43 (-0.47%)
SPVU : 37.68 (-1.64%)
EFV : 49.22 (-0.59%)
Not Santa, Trade Will Rule This December: ETFs to Your Rescue

Despite the age-old trend of a Santa rally, 2018 was a massive downer. Since 2019 is giving the same cues, investors can seek refuge in these safer ETFs.

AMZN : 1,861.64 (-1.22%)
DIA : 289.80 (-0.60%)
XAR : 115.50 (-0.30%)
RTH : 120.10 (-1.45%)
BBH : 135.76 (-1.79%)
ITB : 48.41 (-1.20%)
QQQ : 222.70 (-0.84%)
SPY : 328.77 (-0.89%)
BBY : 89.44 (-0.42%)
WMT : 114.37 (-1.24%)
TGT : 114.32 (-1.05%)
SPVU : 37.68 (-1.64%)
XLC : 55.69 (-1.21%)
A Guide to Biotech ETF Investing

Increasing M&A deals, growing AI dominance and favorable regulatory tidings continue to work in favor of the biotech market.

SBIO : 40.08 (-2.53%)
BBP : 41.88 (-2.23%)
BTEC : 38.91 (+0.07%)
BBH : 135.76 (-1.79%)
XBI : 90.75 (-2.69%)
IBB : 116.88 (-2.19%)
FBT : 145.47 (-2.02%)
CNCR : 22.13 (-2.47%)
PBE : 55.56 (-2.32%)
ARKG : 33.70 (-1.92%)
Why Biotech ETFs Surged in Monday's Trading Session

Increasing M&A deals, growing AI dominance and favorable regulatory tidings continue to drive the biotech market.

NVS : 93.87 (-1.11%)
IBB : 116.88 (-2.19%)
FBT : 145.47 (-2.02%)
BBH : 135.76 (-1.79%)
XBI : 90.75 (-2.69%)
GBT : 73.13 (-8.29%)
VRTX : 229.06 (-2.07%)
CRSP : 54.75 (-3.22%)
Biotech ETF (BBH) Hits New 52-Week High

This biotech ETF hits a new 52-week high. Are more gains in store for this ETF?

AMG : 82.91 (-3.00%)
BBH : 135.76 (-1.79%)
CELG : 108.24 (+0.10%)
GILD : 63.15 (-1.24%)
Risk-On Sentiments Are Back: ETFs to Play

The global market has been rallying hard since October. Investors can thus bet on these high-flying ETFs.

JJC : 41.53 (-1.98%)
ACWI : 80.27 (-0.83%)
USO : 11.43 (-1.97%)
EEM : 44.60 (-0.80%)
BBH : 135.76 (-1.79%)
QMOM : 35.01 (-0.60%)
KBWD : 22.19 (-0.95%)
XLB : 59.74 (-0.71%)
SPY : 328.77 (-0.89%)
Biotech ETFs in Focus on Impressive Q3 Earnings Results

Let's take a look at some ETFs with wide exposure to a few biotechnological companies which released solid Q3 earnings results recently.

BMY : 64.16 (-4.05%)
FBT : 145.47 (-2.02%)
IBB : 116.88 (-2.19%)
XBI : 90.75 (-2.69%)
BBH : 135.76 (-1.79%)
AMGN : 225.59 (-4.02%)
BIIB : 278.14 (-2.14%)
CELG : 108.24 (+0.10%)
ALXN : 105.27 (-3.02%)
GILD : 63.15 (-1.24%)
Value Biotech ETFs & Stocks to Buy Now

Biotech valuation looks attractive amid a volley of good news. Investors can tap these stocks and ETFs.

ABBV : 83.54 (-2.03%)
BMY : 64.16 (-4.05%)
MRK : 85.98 (-2.91%)
RHHBY : 41.2000 (-2.81%)
LLY : 139.07 (-1.52%)
GSK : 47.23 (-1.23%)
XBI : 90.75 (-2.69%)
BBH : 135.76 (-1.79%)
AMGN : 225.59 (-4.02%)
BIIB : 278.14 (-2.14%)
CELG : 108.24 (+0.10%)
IDNA : 28.74 (-1.90%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade BBH with:

Fund Summary

The VanEck Vectors Biotech ETF seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Biotech 25 Index, which is intended to track the overall performance of companies involved in the development and production, marketing and sales of...

See More

Key Turning Points

2nd Resistance Point 140.01
1st Resistance Point 137.89
Last Price 135.76
1st Support Level 134.39
2nd Support Level 133.01

See More

52-Week High 143.02
Last Price 135.76
Fibonacci 61.8% 131.89
Fibonacci 50% 128.46
Fibonacci 38.2% 125.02
52-Week Low 113.89

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar